J R Schoenfeld1, J Y Tom, D G Lowe
1Department of Cardiovascular Research, Genentech, Inc., South San Francisco, CA 94080, USA.
Researchers engineered human B-type natriuretic peptide (hBNP) variants to improve binding to natriuretic peptide receptor-A (NPR-A) over natriuretic peptide receptor-C (NPR-C). A specific mutation (S19R) enhanced NPR-A selectivity 265-fold, offering insights into natriuretic peptide receptor interactions.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: